EC
LUNG icon

EntryPoint Capital’s Pulmonx LUNG Stock Holding History

EntryPoint Capital’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,149
Closed -$92.4K – 865
2024
Q3 		$92.4K Sell
11,149
-24,992
-69% -$181K 0.05% 560
2024
Q2 		$229K Buy
36,141
+25,128
+228% +$193K 0.11% 332
2024
Q1 		$102K Buy
+11,013
New +$129K 0.09% 406

Other funds holding LUNG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

EntryPoint Capital's LUNG Position: Q4 2024 in Review

EntryPoint Capital sold out of Pulmonx (LUNG) in Q4 2024, closing a stake of 11,149 shares — an estimated $92.4K sold.

EntryPoint Capital first reported a position in LUNG in Q1 2024 and held it in 3 quarters. The position peaked at $229K in Q2 2024. 118 funds tracked by Wall St. Rank hold LUNG as of Q4 2024.

  • EntryPoint Capital reported no remaining Pulmonx position as of Q4 2024 after selling out during the quarter.
  • EntryPoint Capital sold 11,149 Pulmonx shares in Q4 2024, an estimated $92.4K.
  • EntryPoint Capital first reported a position in Pulmonx in Q1 2024 and held it in 3 quarters.
  • EntryPoint Capital's Pulmonx position peaked at $229K in Q2 2024.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q4 2024.

Based on EntryPoint Capital's 13F filing for Q4 2024, filed 11 Feb 2025.